Research in our lab indicates that the rapamycin (mTOR) pathway plays a crucial role in VEGF synthesis, and its disruption along the VEGF/NRP1 axis has been linked to the activation of proangiogenic and protumerogenic signaling in both endothelial cells and ccRCC tumor cells [124]. This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.